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Xylella fastidiosa is a Gram-negative bacterium that grows as a biofilm inside
the xylem vessels of susceptible plants and causes several economically
relevant crop diseases. In the present study, we report the functional and
low-resolution structural characterization of the X. fastidiosa disulfide
isomerase DsbC (XfDsbC). DsbC is part of the disulfide bond reduction/
isomerization pathway in the bacterial periplasm and plays an important role
in oxidative protein folding. In the present study, we demonstrate the pres-
ence of XfDsbC during different stages of X. fastidiosa biofilm development.
XfDsbC was not detected during X. fastidiosa planktonic growth; however,
after administering a sublethal copper shock, we observed an overexpression
of XfDsbC that also occurred during planktonic growth. These results
suggest that X. fastidiosa can use XfDsbC in vivo under oxidative stress con-
ditions similar to those induced by copper. In addition, using dynamic light
scattering and small-angle X-ray scattering, we observed that the oligomeric
state of XfDsbC in vitro may be dependent on the redox environment. Under
reducing conditions, XfDsbC is present as a dimer, whereas a putative
tetrameric form was observed under nonreducing conditions. Taken
together, our findings demonstrate the overexpression of XfDsbC during bio-
film formation and provide the first structural model of a bacterial disulfide
isomerase in solution.
Structured digital abstract
• XfDsbC and XfDsbC bind by x ray scattering (View Interaction: 1, 2)
• XfDsbC and XfDsbC bind by molecular sieving (View interaction)
• XfDsbC and XfDsbC bind by comigration in non denaturing gel electrophoresis (View inter-
action)
• XfDsbC and XfDsbC bind by cross-linking study (View Interaction: 1, 2)
• XfDsbC and XfDsbC bind by dynamic light scattering (View Interaction: 1, 2)
Abbreviations
DLS, dynamic light scattering; EcDsbC, Escherichia coli DsbC; HiDsbC, Haemophilus influenzae DsbC; PDB, Protein Data Bank; Rg, radius
of gyration; SAXS, small-angle X-ray scattering; TCEP, tris(2-carboxyethyl)phosphine; XcDsbC, Xanthomonas campestris DsbC;
XfDsbC, Xylella fastidiosa disulfide isomerase DsbC; XfDsbCN-Red, nonreduced XfDsbC; XfDsbCRed, reduced XfDsbC.
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Introduction
Disulfide bond formation is a critical step for the cor-
rect folding of many proteins that are rich in cysteine
residues. In addition to conferring a stable structure,
disulfide bonds play a regulatory role by changing the
shape, surface charge or reactivity of some proteins [1].
Among the Gram-negative bacteria, the Dsb protein
family constitutes the oxidative protein folding machin-
ery and plays an important role in disulfide bond for-
mation in the periplasm [2–5]. The enzymatic pathway
of the Dsb protein family is well characterized in Esc-
herichia coli and is composed of five members: DsbA,
DsbB, DsbC, DsbD and DsbG [5]. These proteins are
typically oxidoreductases and contain a CXXC motif
(cysteine residues separated by two amino acids) in the
catalytic site, similar to thioredoxin-like proteins [6].
Chemically, DsbA, which is a strong thiol oxidant,
catalyzes disulfide bond formation [7,8]. DsbA rapidly
oxidizes cysteine residues in proteins that are located
in the periplasm by introducing a disulfide bond that
is more energetically favourable for correct protein
folding [9]. However, two cysteines can be incorrectly
joined in a disulfide bond that does not appear in the
native protein conformation. When mis-oxidized, the
non-native disulfide bond may be reduced or rear-
ranged to ensure that correct protein folding is
achieved. DsbC catalyzes this step in the reduction/
isomerization pathway [4,10,11].
Two models have been proposed to explain how
E. coli DsbC (EcDsbC) reshuffles proteins containing
incorrect disulfide bonds [5]. However, the biological
role of DsbC in other bacteria is not completely under-
stood. In addition to isomerase activity, DsbC exhibits
certain chaperone-like properties [12], and this func-
tion appears to be independent of the two cysteines in
the active site CXXC motif [13]. The isomerase and
chaperone activities of DsbC are important for bacte-
rial pathogenicity because these activities ensure the
correct folding in a wide range of proteins, including
secreted virulence factors and surface components such
as adhesins and pili [14].
An interesting aspect of the disulfide bond isomeri-
zation mechanism is that the active-site cysteine resi-
dues must remain reduced for DsbC activity. This
characteristic is particularly intriguing because DsbC
acts in the bacterial periplasm, which is an oxidizing
environment. DsbD, a transmembrane protein that
transfers reducing equivalents from the cytosol to the
periplasm, is responsible for maintaining DsbC in the
reduced and active state [10,15].
Interestingly, a study of eukaryotic protein disulfide
isomerase, which is topologically analogous to pro-
karyotic DsbC, revealed an intramolecular structural
rearrangement between the catalytic and noncatalytic
domains that was dependent on the environmental
redox state [16]. Protein disulfide isomerase is com-
posed of two catalytic domains (a and a′) that are sep-
arated by two noncatalytic domains (b and b′) and a
third domain (c) [17]. Correspondingly, EcDsbC is
described as a V-shaped homodimeric protein in which
each monomer contains an N-terminal dimerization
domain that is joined by a hinged linker to the C-ter-
minal catalytic domain [18].
In E. coli mutants lacking dsbC, many cysteine-rich
proteins exhibited reduced activity or were degraded
[11,19,20]. However, the most expressive phenotype
observed in dsbC-null mutants is an increased sensiti-
vity to copper (a redox-active metal), which indicates
that DsbC is required for the oxidative stress response
[21].
In the present study, we report the functional and
structural characterization of DsbC from the 9a5c
strain of Xylella fastidiosa (XfDsbC) by small-angle
X-ray scattering (SAXS). X. fastidiosa is a Gram-nega-
tive bacterium that grows as a biofilm in the xylem
vessels of susceptible plants and causes many diseases
in commercial crops around the world, including citrus
variegated chlorosis, an economically important crop
disease that compromises sweet orange production in
Brazil [22,23]. We characterized XfDsbC to evaluate
its role in biofilm formation, which blocks the xylem
and causes the onset of disease. The results obtained
demonstrate that XfDsbC expression occurs during
bacterial biofilm formation and is enhanced under oxi-
dative stress conditions. In addition, using modelling
approaches based on the SAXS data, we provide
evidence for a possible redox-dependent oligomeric
modulation of XfDsbC in vitro.
Results
XfDsbC is involved in biofilm formation and the
copper stress response
We investigated the involvement of XfDsbC in X. fas-
tidiosa biofilm formation and development. XfDsbC
was successfully cloned, and the protein was purified
by affinity chromatography. XfDsbC has a molecular
mass of 29.5 kDa, which corresponds to the 263-
amino acid sequence encoded by ORF Xf1177 plus the
C-terminal His6-Tag added by the pET29a(+) vector.
Titration of the number of free cysteines revealed that
the recombinant XfDsbC was purified in an oxidized
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state as reported previously [24]. Polyclonal antibodies
against XfDsbC were produced and used for western
blot analysis. We observed a differential expression
pattern of XfDsbC during X. fastidiosa biofilm forma-
tion and planktonic cell growth (Fig. 1). XfDsbC was
expressed during all phases of biofilm development.
However, during the planktonic growth phase of
X. fastidiosa, XfDsbC was poorly expressed and could
not be detected by western blotting (Fig. 1A). How-
ever, after administering a sublethal copper shock, the
planktonic cells overexpressed XfDsbC (Fig. 1B). The
samples were normalized against total protein concen-
tration before gel loading to ensure that the same
amount of protein was evaluated for each condition.
These results suggest that X. fastidiosa can use
XfDsbC in vivo under oxidative stress conditions simi-
lar to those induced by copper. The statistical analysis
of the ratio of the intensity and area (pixels) of the
bands visualized on nitrocellulose membranes revealed
statistically significant differences (P < 0.05) in the
expression profiles of XfDsbC (Fig. 1C, D). Under
copper-induced oxidative stress, the expression of
XfDsbC was only significantly greater in biofilms than
in planktonic cells after 5, 10 and 30 days of biofilm
growth (Fig. 1D). The intensities of the protein bands
corresponding to XfDsbC in the different phases of
biofilm formation in the presence or absence of cop-
per stress were similar to the profiles observed for
planktonic cells and biofilms exposed to copper shock.
At 15 and 20 days, there were no significant differ-
ences (P < 0.05) in XfDsbC expression between bio-
films in the presence or absence of copper. However,
at 3 and 5 days, XfDsbC was expressed in larger
quantities in the biofilms that were not treated with
copper, whereas, at 10 and 30 days, XfDsbC was
expressed in larger quantities in the biofilm cells that
were subjected to copper stress (Fig. 1C, D).
XfDsbC expression complements the
dsbC-defective E. coli mutant
The thiol-disulfide reductase activity of purified nonre-
duced XfDsbC (XfDsbCN-Red) was confirmed in vitro
using the rate of insulin disulfide reduction (Fig. 2A).
As expected, the activity of XfDsbC was comparable to
that of EcDsbC. The insulin reduction rate of XfDsbC
was 0.0126 (DA650min2), which was approximately
88% of the activity of EcDsbC [0.0143 (DA650min2)].
In addition to the reductase activity, the disulfide bond
isomerase activity of XfDsbC was assessed in vivo in a
dsbC E. coli mutant. This dsbC-defective E. coli mutant
was used because an appropriate methodology for the
construction of the X. fastidiosa 9a5c mutants is not
yet available. DsbC isomerase activity is required for
A
B
C
D
Fig. 1. XfDsbC expression in X. fastidiosa is elevated during biofilm formation and the oxidative stress response. Total protein samples
were isolated from different biofilm growth phases and planktonic cells (see Experimental procedures), normalized using BCA quantification,
and evaluated by western blot analysis using polyclonal antibodies against XfDsbC in the absence (A) or presence (B) of oxidative stress
induced by copper. (C) The XfDsbC expression profiles of biofilm (black bars) and planktonic (grey bars) cells in the absence or (D) presence
of copper were quantified using EDAS software. The bars represent the mean of three independent experiments. The error bars indicate the
SE obtained from triplicate experiments. Asterisks indicate statistically significant differences (P < 0.05, t-test).
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tolerance to copper, a redox-active metal [21]. Copper
is a nonspecific thiol oxidant that leads to protein mis-
folding through the establishment of non-native disul-
fide bonds. The DsbC reduction/isomerization pathway
acts to reverse protein misfolding by rearranging the
disulfide bonds and promoting native protein folding.
XfDsbC expression complemented the dsbC E. coli
mutant under the oxidative stress conditions induced
by copper (i.e. the transformation of the dsbC mutant
strain with pBAD24-xfdsbC restored the wild-type phe-
notype) (Fig. 2B). In addition, western analysis of
XfDsbC in dsbC cells containing pBAD24-xfdsbC
that were grown on plates containing 8 mM CuCl2
(Fig. 2C) strongly suggests that the increased cell via-
bility under this condition is correlated with the pres-
ence of XfDsbC. Our findings show that the basal
expression of xfdsbC can support the growth of the
dsbC E. coli mutant strain even in the absence of
L-arabinose, which induces the arabinose operon in the
pBAD24 vector (data not shown).
Initial characterization of XfDsbC
The initial analysis of the amino acid sequence of
XfDsbC revealed the presence of 21 N-terminal amino
acid residues that are not present in the homologous
EcDsbC and Erwinia chrysanthemi proteins (Fig. S1).
Interestingly, these additional N-terminal amino acids
are also found in the bacterium Xanthomonas campestris
DsbC (XcDsbC), which has host specificity for the same
citrus plants infected by X. fastidiosa. Four cysteine res-
idues similar to those observed in the 3D structure of
EcDsbC [18] are present in the thioredoxin-like domains
of XfDsbC. The Cys143 and Cys146 residues of
XfDsbC (active site) correspond to Cys98 and Cys101
of the EcDsbC crystal structure [Protein Data Bank
(PDB) code: 1EEJ], and the Cys186 and Cys208 residues
of XfDsbC (non-active site) correspond to Cys141 and
Cys163 of EcDsbC. These cysteine residues are strongly
conserved between DsbC homologues and, because
DsbC can undergo structural changes that are depen-
dent on the redox environment, these cysteine residues
may be directly or indirectly involved in structural rear-
rangements and function. Therefore, we evaluated
whether the redox environment caused changes in the
structure of XfDsbC in vitro. XfDsbC samples in the
presence or absence of reducing agents were analyzed
using SDS/PAGE, native gel electrophoresis, CD,
size-exclusion chromatography, fluorimetry, chemical
cross-linking and dynamic light scattering (DLS).
A
B C
Fig. 2. XfDsbC functionally complements a dsbC-null E. coli mutant. (A) The XfDsbCN-Red (▲) thiol-reductase activity was confirmed in vitro
using the insulin disulfide reduction assay. EcDsbC (■) and a test without catalyst (♦) were used as positive and negative controls, respectively.
(B) The XfDsbC disulfide bond isomerase activity was assessed in vivo for its ability to complement an E. colimutant lacking dsbC (dsbC). The
dsbC phenotypes of the various strains (wild-type, dsbC, dsbC containing pBAD24-xfdsbC, and dsbC with a wild-type ecdsbC gene or
empty vector) were evaluated by spotting 5 lL of 10-fold serial dilutions onto BHI agar plates with the appropriate antibiotic and containing 4 or
8 mM CuCl2 with 0.002% (w/v) L-arabinose. The plates were incubated overnight at 37 °C, and the ability of XfDsbC to restore the wild-type
phenotype was analyzed. (C) The expression of XfDbsC in the dsbC strain was confirmed by western blot analysis.
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Under denaturing conditions in the presence and
absence of b-mercaptoethanol, XfDsbC was present in
the gel as a single band at approximately 29 kDa,
which corresponds to the molecular mass of the mono-
mer. Under nondenaturing conditions, XfDsbC sam-
ples exhibited the same gel migration profile in the
presence and absence of tris(2-carboxyethyl)phosphine
(TCEP). This profile was more similar to that of con-
albumin (75 kDa) than that of aldolase (158 kDa)
(Fig. 3A). The CD analysis revealed a typical protein
spectrum with a predominantly a-helical structure
(38% helical/18% sheet), similar to that for EcDsbC
calculated from its crystal structure [18]. There were
no significant differences in the secondary structure
content of XfDsbC in the presence or absence of
TCEP (data not shown).
Analytical size-exclusion chromatography of reduced
and nonreduced XfDsbC confirmed the native gel
results, indicating that there were no differences
between the two tested conditions (Fig. 3B). Both the
reduced and nonreduced protein samples eluted as sin-
gle peaks in the gel filtration assays, with retention
times that corresponded to apparent molecular masses
of 60.2 and 61.7 kDa, respectively (Fig. 3B). Different
buffer and pH conditions, as well as XfDsbC oxida-
tion under atmospheric oxygen, were evaluated, and
no differences were observed in the elution profiles of
the samples in the presence or absence of the reducing
agent (data not shown).
The conformational changes in the XfDsbC protein
samples under reducing or nonreducing conditions
were next analyzed by fluorimetry, and tryptophan
emission was used as a probe to monitor DsbC fold-
ing. XfDsbC contains a tryptophan residue that neigh-
bours Cys186, which is distal from the active site
(Fig. S1). This cysteine residue can establish a disulfide
bond with Cys208 and likely plays a role in XfDsbC
folding. The fluorescence spectra recorded upon excita-
tion at 280 nm showed that reduction with TCEP
increased the intrinsic fluorescence intensity and
shifted the maximum emission wavelength from 307 to
310 nm (Fig. 3C).
Although XfDsbC can exist predominantly as
dimers in solution, and SDS/PAGE, nondenaturing gel
electrophoresis, CD and size-exclusion chromatogra-
phy did not reveal any redox-dependent structural
A B
DC
Fig. 3. Initial characterization of XfDsbC. (A) XfDsbC nondenaturing polyacrylamide gel electrophoresis in the presence (+) and absence ()
of TCEP. (B) Size-exclusion chromatography calibration curves for XfDsbCRed and XfDsbCN-Red. The monomeric molecular mass for XfDsbC
is 29.5 kDa, and the expected molecular mass for the XfDsbC dimer is 59 kDa. The estimated molecular masses for XfDsbCRed and
XfDsbCN-Red were 60.2 and 61.7 kDa, respectively. (C) XfDsbC fluorimetry spectra of XfDsbCRed and XfDsbCN-Red are shown as squares and
circles, respectively. (D) Glutaraldehyde cross-linking of XfDsbC in the absence (XfDsbCN-Red) and presence (XfDsbCRed) of TCEP. The
XfDsbC samples (5 lM) were treated with increasing concentrations of glutaraldehyde (0%, 0.025%, 0.05% and 0.1%), and the products
were evaluated by western blot analysis using polyclonal antibodies against XfDsbC.
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changes in XfDsbC, higher-order oligomeric species
that appear to correspond to tetramers were observed
in vitro under the nonreduced condition of XfDsbC
(Fig. 3D, lanes 1–4) after chemical cross-linking with
glutaraldehyde, along with dimeric and monomeric spe-
cies (Fig. 3D, lanes 2–4). However, only dimeric forms,
in addition to monomeric species, were observed under
the reduced condition (Fig. 3D, lanes 5–8). These slow-
migrating species were not observed in the absence of
glutaraldehyde (Fig. 3D, lanes 1 and 5).
We also used DLS analysis to assess the redox-
dependent oligomeric modulation of XfDsbC. The
results of this analysis showed that, under both nonre-
duced and reduced conditions, XfDsbC showed a low
index of polydispersity (%Pd; 9.5 and 5.8, respectively)
(Table 1). In addition, the molecule in solution under
the nonreduced condition presents a hydrodynamic
diameter (Dh) of 4.6 nm and differs from that
observed under the reduced condition which has a Dh
of 3.8 nm, indicating of the presence of a high oligo-
mer form of XfDsbC under the nonreduced condition.
SAXS analysis suggests a redox-dependent
oligomeric assembly of XfDsbC in vitro
XfDsbC SAXS scattering curves collected in the pres-
ence and absence of reducing agent were analyzed.
The scattering curves of 4- and 7-mgmL1 protein
samples in the presence of 3 mM TCEP [reduced
XfDsbC (XfDsbCRed)] were collected. The 7-mgmL1
samples exhibited interparticle interference effects that
compromised further analysis, although the curves
collected from 4-mgmL1 samples did not exhibit this
behaviour. Therefore, the scattering curves of XfDsbC
at 4 mgmL1 were selected for SAXS data analyses
and model construction. The superimposition of the
20 scattering curves collected for XfDsbCRed at
4 mgmL1 revealed a transition during the data
collection that may be the result of conformational
changes arising from radiation damage. Therefore,
only the first curve was used for further analysis
(Fig. 4A). As shown in Fig. 4A (inset), the constructed
XfDsbCRed Guinier plot demonstrated a linear behav-
iour, indicating sample monodispersity. The Guinier
analysis revealed a radius of gyration (Rg) of 31.2 A˚.
XfDsbCRed Kratky plots were also constructed
(Fig. 4B) and displayed a well-defined maximum,
which is expected for the native state of a compact
globular protein. The molecular mass of the scattering
particles was estimated to be 66 kDa by SAXS MOW
software [25]. This suggests that XfDsbCRed is a dimer
in solution, similar to other DsbC proteins [18,26].
The XfDsbCRed distance distribution function, P(r),
showed a maximum intramolecular distance (Dmax) of
100 A˚ (Fig. 4D). The Rg calculated from the P(r) was
31.5 A˚, which is consistent with the values obtained
from the Guinier analysis.
Scattering curves were collected from 1, 4 and
13 mgmL1 XfDsbC in the absence of TCEP
(XfDsbCN-Red). However, the curves at 1 mgmL1
were too dilute for SAXS data collection and resulted
in weak scattering curves. The molecular masses esti-
mated from the 4- and 13-mgmL1 samples were iden-
tical. For consistency with the XfDsbCRed samples,
we selected the XfDsbCN-Red curves collected at
4 mgmL1 for further analyses. As observed for
XfDsbCRed, the XfDsbCN-Red protein samples suffered
radiation damage. Therefore, only the first curve was
selected (Fig. 4C). The XfDsbCN-Red Guinier region is
displayed in Fig. 4C (inset). From the Guinier analy-
sis, an Rg of 35.4 A˚ was calculated. The Kratky plot
was also evaluated (Fig. 4B) and showed a defined
maximum with smaller q values than those of the
XfDsbCRed maximum, which indicates a larger
XfDsbCN-Red scattering particle. The XfDsbCN-Red
molecular mass obtained in the absence of TCEP was
estimated to be 117 kDa, suggesting that, in the
absence of reducing agent, an XfDsbC tetramer is
formed in solution. The XfDsbCN-Red P(r) had a Dmax
of 130 A˚ (Fig. 4D), and the distance peak was concen-
trated at small distances, indicating a prolate
XfDsbCN-Red structure. A second estimation of the Rg
calculated from the P(r) was 38.4 A˚, which is consis-
tent with the values obtained in the Guinier analysis.
The XfDsbC tetramer appears to be compact and
distinct from the joining of two dimers
The monomeric XfDsbC homology model con-
structed with the I-TASSER server exhibited similarities
to the EcDsbC [18] and Haemophilus influenzae DsbC
(HiDsbC) [27] proteins. The amino acid sequence
Table 1. Hydrodynamic diameters (Dh), percentage of sample
polydispersity (% Pd), estimated molecular weights from the
measured radius (MW-R), percentage of sample intensity (% Int)
and estimated relative amount of mass (% Mass) of each species
determined from DLS analysis of XfDsbC in the presence
(XfDsbCN-Red) or absence (XfDsbCRed) of a reducing agent.
Sample Dh (nm) % Pd MW-R (kDa) % Int % Mass
XfDsbCN-Red 4.6 9.5 119 73 99.6
XfDsbCRed
a 3.8 5.8 75 72 99.5
a To ensure complete protein reduction, XfDsbC was incubated
with a freshly prepared solution of TCEP at a final concentration of
3 mM for 1 h before the DLS experiments.
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similarity of these two proteins to XfDsbC is approxi-
mately 35%. As observed in the structures of EcDsbC
and HiDsbC, the constructed XfDsbC model displays
two distinguishable domains: the dimerization and cata-
lytic domains. The dimerization domain is small and is
composed of 58 residues (residues 20–77) that form a
b-strand, a turn and an a-helix. The catalytic domain is
the largest domain and displays a thioredoxin-like fold.
The XfDsbC catalytic domain is comprised of residues
86–244 and harbours the active site cysteine residues
(Cys143 and Cys146 in XfDsbC, which correspond to
Cys98 and Cys101 in EcDsbC). The catalytic domain is
connected to the dimerization domain by a poorly
modelled hinge. To construct the XfDsbC dimer, the
3D structure of the constructed monomer homology
model was superimposed on the crystal structure of the
EcDsbC dimer (PDB code: 1EEJ). A second XfDsbC
chain was generated and superimposed on the remain-
ing EcDsbC monomer. The putative XfDsbC dimer
interface was proposed based on the high-resolution
structures, chimeric constructs and site-directed muta-
genesis of other DsbC dimeric proteins [18,26–28]. The
dimerization domains of EcDsbC and HiDsbC are
primarily connected by hydrogen-bond interactions
formed by main chain residues from two external anti-
parallel b-strands. An ionic interaction between
EcDsbC His45 and Asp53 also contributes to the stabil-
ity of the dimer and protein isomerase activity [26,29].
Therefore, the conservation of this characteristic inter-
face in the XfDsbC structure was investigated. Accord-
ing to the XfDsbC homology model, XfDsbC has an
external b-strand in its dimerization domain. The
b-strand enables anti-parallel main chain contacts
between the two XfDsbC dimerization domains and
likely involves residues 68–77. An arginine (Arg68) and
an aspartate (Asp77) residue are located on the extremi-
ties of this b-strand. Because Arg and Asp are oppo-
sitely charged, it is possible that ionic interactions help
to stabilize the XfDsbC dimer, as observed in EcDsbC
[26,29].
A C
DB
Fig. 4. XfDsbC SAXS analysis under reducing and nonreducing conditions. XfDsbC SAXS data analysis from samples collected in the presence
(XfDsbCRed) or absence (XfDsbCN-Red) of TCEP. (A) XfDsbCRed scattering curve (open squares) and BUNCH curve (solid line) fitting. (B) Kratky
plots. (C) XfDsbCN-Red scattering curve (open circles) and SASREF curve (solid line) fitting. The Guinier regions are shown in the insets A and C. (D)
distance distribution functions [P(r)]. The Kratky plots and [P(r)] were calculated for q values in the range 0.0197–0.3008 A˚1 for XfDsbCRed and
0.0351–0.2152 A˚1 for XfDsbCN-Red. The XfDsbCRed and XfDsbCN-Red plots are shown as squares and circles, respectively.
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Based on this potential XfDsbC dimeric interface,
the XfDsbC dimer was modelled according to the
experimental XfDsbC low-resolution scattering curve.
In this step, the XfDsbC dimerization domains and
catalytic domains were provided as individual chains
to the software suite BUNCH. Restraints were imposed
to prevent the domains from being too far apart and
to maintain the dimerization interface. A maximum
distance from the centre of mass of each dimerization
domain and catalytic domain to residues 68–77 of the
two dimerization domains was set to maintain the
dimerization interface and preserve the proximity of
the catalytic domains and dimerization domains. The
linker region (residues 78–85) that connects the dimer-
ization and catalytic domains was removed from the
input sequence, and the software was allowed to model
these flexible regions. More than 40 XfDsbC atomic
models were generated by BUNCH, and these models
showed a good fit to the experimental SAXS curves,
with chi-squared values of approximately 2.5. These
models were visually inspected and sorted into three
major groups that primarily differed in the orientation
of the catalytic domains. In one of these groups, the
catalytic Cys125 was turned away from the catalytic
cleft and was exposed to the solvent, which would
likely limit the activity of the protein. The cleft formed
by the two catalytic domains has been suggested to
play an important role in substrate recognition and
protein activity [26] because the catalytic cysteine resi-
due is oriented in the direction of this cleft in the
known DsbC crystal structures. Therefore, the models
with the cysteine facing away from the cleft were con-
sidered to have an improbable catalytic domain orien-
tation and were discarded. The remaining models were
carefully inspected and further clustered into two
groups. The first group was comprised of models that
followed the dimerization and catalytic domain orien-
tations predicted by known DsbC crystal structures
(Fig. 5A). The second group included models with
intertwined dimerization and catalytic domains (named
‘inverted dimers’; Fig. S2). It was difficult to evaluate
the correctness of these two groups of XfDsbC dimer
models because both models are possible given the
low-resolution data. However, because the models in
the first group were most similar to the reported DsbC
crystal structures, one of the dimers from this group of
models was selected for further analysis (Fig. 5A).
The selected XfDsbC SAXS dimer model is similar
to the EcDsbC dimer crystal structure (PDB code:
1EEJ). The dimerization domains are connected by
contacts mediated by two b-strand-like secondary
structural elements on the surface of each dimerization
domain. The dimer displays a V-shaped conformation,
and a potential catalytic cleft is formed between the
two catalytic domains. This cleft has an internal angle
of approximately 60°, suggesting that XfDsbC is
slightly closed in comparison to EcDsbC (internal cleft
angle of approximately 70°). The catalytic XfDsbC
cysteine residue (Cys143) and its disulfide bond partner
(Cys146) are positioned close to the catalytic cleft.
However, the adjacent structural cysteines (Cys186
and Cys208) are oriented in opposite directions and
are slightly exposed to the solvent.
It was not possible to model the XfDsbC tetramer
using a rigid-body fit for the SAXS-modelled XfDsbC
dimer described above, which suggests that the XfDsbC
dimer undergoes domain orientation and/or conforma-
tional changes to form the tetramer. Therefore, in an
attempt to model a putative XfDsbC tetramer, four
A B
Fig. 5. The oligomeric assembly of XfDsbC responds to the
environmental redox state in vitro. The suggested XfDsbC dimer
(A) and tetramer (B) were modelled based on SAXS curves. The 3d
XfDsbC atomic model for the dimer was generated using BUNCH,
whereas the tetramer was modelled with SASREF. P2 symmetry
was imposed in both cases. In both strategies, the dimerization
and catalytic domains were inputted as independent entities, and
only a few constraints were imposed for model generation. The
low-resolution protein envelopes, which were constructed with
DAMMIF software, are shown as semi-transparent whitish spheres
superimposed on the atomic models. The middle views are rotated
by 90° around the x-axis, clockwise in (A) and counterclockwise in
(B). The bottom views in both panels are rotated 90° clockwise
around the y-axis. The figures were generated USING PYMOL
(Schrodinger LLC).
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XfDsbC dimerization and catalytic domains were input-
ted into SASREF software as individual chains. Using this
strategy, SASREF was able to model an XfDsbC tetramer
using only a few constraints.
The models obtained from different runs were
judged to be similar by visual inspection. One of the
XfDsbC tetrameric models is presented in Fig. 5B.
The chi-squared value obtained for the comparison of
the XfDsbCN-Red SAXS curve with the modelled tetra-
mer is 1.6, which indicates an excellent fit and the cor-
rectness of the model. The modelled XfDsbC tetramer
is formed by interchain contacts between two catalytic
domains from different dimers and likely involves
domain reorientation, as noted above.
Curiously, the XfDsbC tetrameric models were simi-
lar to the DsbC oligomeric structures generated by
applying symmetric operations to DsbC crystal struc-
tures (Fig. S3). This observation may support the pos-
sibility that larger oligomers of DsbC proteins can
form.
Discussion
The XfDsbC protein was annotated in the X. fastidiosa
9a5c genome as being involved in pathogenicity,
adaptation and survival [30]. Functional and struc-
tural studies of proteins in this category have helped
determine how this bacterium has adapted to plant
hosts and provide a better understanding of the mecha-
nisms underlying pathogenicity and bacterial virulence
[31–34].
Biofilm formation is considered to be the primary
mechanism of pathogenicity by X. fastidiosa [35]. The
phases of X. fastidiosa biofilm development have been
defined previously [34,36]. The initial adhesion phase
of the cells to the substrate occurs after 3–5 days.
Within 10 days, micro-colonies are formed, followed
by a maturation phase that occurs between 15 and
20 days after adhesion. The development of the bio-
film architecture begins at approximately 15 days, and
the biofilm is fully mature within 20 days. The last
stage of biofilm formation, the dispersion phase,
occurs between 25 and 30 days after adhesion.
We confirmed that XfDsbC is involved in bacterial
pathogenicity by demonstrating its expression during
X. fastidiosa biofilm formation. Interestingly, XfDsbC
is poorly expressed during X. fastidiosa planktonic
growth, suggesting that, under these conditions, the
disulfide bond isomerization pathway is largely not
required for bacterial survival. The frequency of the
formation of non-native disulfide bonds by DsbA is
low under normal bacterial growth conditions [37],
which explains the minimal requirement for XfDsbC
during X. fastidiosa planktonic growth. Biofilm growth
provides greater adaptive advantages than planktonic
growth by coordinating the growth rate, which pro-
vides the cells with increased resistance to antimicro-
bial agents, such as metals [38]. Thus, stress response
pathways, including mechanisms that promote sur-
vival, have a major role in the success of bacterial bio-
film formation [39]. The disulfide bond isomerization
pathway in which XfDsbC plays its primary role com-
prises one such survival mechanism because it is
directly involved in protein folding [2–5,10].
Cells exhibit different gene expression and metabolic
profiles during biofilm and planktonic growth [34,40].
In the present study, we demonstrated, by direct im-
munodetection, that XfDsbC is differentially expressed
during X. fastidiosa planktonic and biofilm growth.
Interestingly, in response to metal stress, planktonic
X. fastidiosa overexpresses XfDsbC, with expression
levels similar to those observed in mature biofilms.
Our findings reveal that X. fastidiosa can use XfDsbC
in vivo as a response to oxidative stress, which is cor-
roborated by the finding that XfDsbC is able to com-
plement a dsbC-null E. coli mutant under similar stress
conditions. However, during the mature biofilm stage,
copper does not appear to affect the expression profile
of XfDsbC. At this stage, the complete structure of
the biofilm makes the cells less responsive to changes
in the external environment [38–40]. Therefore, the
expression of XfDsbC at the mature biofilm stage in
the presence or absence of copper reflects the response
to bacterial growth under biofilm growth conditions,
as opposed to a specific response to metal stress. The
initial stage of X. fastidiosa biofilm development is
marked by the production of many cysteine-rich pro-
teins, including pili and adhesin proteins [34]. The
increased expression of XfDsbC during biofilm forma-
tion may be related to the increased expression of cys-
teine-rich proteins and the need to fold these proteins
correctly. Moreover, the differences observed between
biofilms in the presence and absence of copper appear
to indicate that the bacterial cells are more susceptible
to changes in the external environment during micro-
colony formation and biofilm dispersal; increased
XfDsbC expression appears to be a coordinated cellu-
lar action in these phases. At the stage of cell adhesion
to the substrate, the cells may rely on mechanisms out-
side of the isomerization pathway to respond to oxida-
tive stress, resulting in a decreased level of XfDsbC
expression under these conditions.
In addition to disulfide bond reductase and isomer-
ase activity, DsbC proteins have chaperone activity
[12,13]; however, the mechanism of this activity is not
completely understood for DsbC. One intrinsic feature
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of a chaperone-like protein is the formation of large
oligomers that facilitate interactions between proteins
and their substrates [41]. The detection of XfDsbC
tetramers by DLS and SAXS under nonreducing con-
ditions may be evidence of chaperone activity. How-
ever, whether this oligomeric state occurs in vivo is
unclear.
DsbC homologues have always been described as
homodimers [18,26–28], and their disulfide bond reduc-
tion/isomerization activity is partly correlated with this
state [2–5]. However, Arredondo et al. [26] observed
evidence for a linked EcDsbC with a single active
thioredoxin domain in a tetrameric state using multi-
angle light scattering. The hydrodynamic radius of the
tetramer was 4.4 nm, which is not consistent with the
radius of the dimer (3.8 nm) and suggests that the tet-
ramer is a compact molecule [26]. These results are in
accordance with our findings of DLS and, similarly,
the compact form of EcDsbC tetramer appears to be
consistent with the XfDsbC tetramer that we observed
in vitro in the SAXS analysis.
We did not observe any differences between the
reduced and nonreduced forms of XfDsbC by size-
exclusion chromatography or native gel electrophore-
sis. However, DLS and SAXS analyses demonstrated
the influence of a reducing agent in the folding state of
XfDsbC. Thus, it is possible that the reducing agent-
mediated XfDsbC dimer-tetramer modulation is not
directly linked to disulfide bond formation at the tetra-
mer interface. Rather, it appears that, under nonreduc-
ing conditions, certain amino acid residues may be
exposed, promoting XfDsbC tetramer formation. By
contrast, under reducing conditions, disulfide bond
breakage hinders or hides this interface. The current
low-resolution data do not clarify the mechanism that
guides XfDsbC tetramer assembly.
Based on fluorimetry analysis in which the disulfide
reduction increases fluorescence emission, we can
assert that changes in the folding state of XfDsbC are
related to disulfide bond formation between Cys186
and Cys208, which are equivalent to Cys141 and
Cys163 in EcDsbC [18]. Interestingly, the disulfide
bond formed between these cysteine residues has a
substantial structural role in EcDsbC folding [24].
Therefore, the absence of differences in XfDsbC
behaviour by size-exclusion chromatography and
native gel electrophoresis could be explained by the
weakness of the tetramerization interface, which may
not be maintained under the drag and pressure condi-
tions of chromatography and electrophoresis because a
tetrameric form of XfDsbC was observed in vitro by
chemical cross-linking at low protein concentration
only under the nonreduced condition.
Previous studies in which amino acid residues
important for EcDsbC dimerization were replaced
have shown that the dimeric disulfide isomerase is con-
verted into a monomeric protein that retains oxidase
activity, similar to DsbA [29,42], suggesting that
dimerization acts to protect the DsbC active sites from
DsbB-mediated oxidation [29,43]. Tetramer formation
may play a similar role for XfDsbC, for example, in
preventing the reduction of the disulfide bonds. Bioin-
formatics estimates have revealed that more than 300
E. coli proteins that contain multiple cysteines are
exported to the periplasm [44,45] and may be sub-
strates for disulfide bond-forming enzymes [5]. Thus,
the XfDsbC redox-dependent modulation observed
in vitro may be involved in substrate recognition and
specificity, comprising a role that has not been previ-
ously described for DsbC homologues.
Experimental procedures
Bacterial strain and in vitro growth conditions
X. fastidiosa subsp. pauca 9a5c [46] and E. coli strains
DH5-a, C43 (DE3) (Avidis, Saint-Beauzire, France),
JW2861 and BW25113 [47] were used in the present study.
Before in vitro culture, the X. fastidiosa cells were inocu-
lated into susceptible sweet orange trees to maintain their
pathogenicity [34]. The infected plants developed symptoms
typical citrus of variegated chlorosis, and the bacteria were
isolated. X. fastidiosa was grown in Periwinkle Wilt media
[48] at 130 r.p.m. and 28 °C, and the E. coli strains were
cultured in LB or Brain-Heart Infusion Broth (BHI;
HiMedia, Mumbai, India) media at 200–300 r.p.m. and
25–37 °C, with antibiotic supplementation as necessary.
The X. fastidiosa biofilm and planktonic cells were
obtained using a protocol established by De Souza et al.
[36] and a sublethal copper shock with 1 mM CuSO4 was
applied for 24 h as indicated.
Cloning, expression and purification
The coding sequence of the xfdsbC ORF Xf1177 (798 bp)
was amplified from X. fastidiosa genomic DNA by PCR
with the specific oligonucleotides Xf1177petF (5′-CC
AAACATATGTACCGCCTTATCGTCGCCTTG-3′) and
Xf1177petR (5′-AAACTCGAGGCCCCCTTTAGCTGTT
GCGG-3′), which contained NdeI and XhoI restriction
sites, respectively. The PCR amplification product was
cloned into the pET29a(+) (Novagen, Madison, WI, USA)
expression vector, which added a C-terminal six-histidine
tag to the coding sequence. Sequence analysis of the cloned
vector did not reveal any base substitutions. To overexpress
XfDsbC in E. coli C43 (DE3) cells, the cells were grown at
37 °C in 1 L of LB containing 30 lgmL1 kanamycin until
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D600 of 0.6–0.8 was reached. The expression of the recom-
binant protein was induced by the addition of 5.6 mM
lactose followed by cultivation for 18 h at 25 °C and 200 r.
p.m. The culture was harvested by centrifugation (3000 g
for 15 min at 4 °C) and then the cell pellets were resus-
pended in 50 mL of buffer A (50 mM Tris-HCl, pH 7.5,
300 mM NaCl) plus 1 mgmL1 lysozyme and 1 mM phen-
ylmethanesulfonyl fluoride (Sigma, St Louis, MO, USA)
and incubated on ice for 30 min. The cells were disrupted
by sonication, and the unbroken cells and debris were
removed by centrifugation (27 000 g for 40 min at 4 °C).
The XfDsbC protein was purified in a single chromato-
graphic step on a Ni-NTA column (Qiagen, Hilden, Ger-
many) equilibrated in buffer A. The purified XfDsbC
protein was eluted with five column volumes of buffer A
containing 250 mM imidazole, and the purity was estimated
using SDS/PAGE. The affinity-purified XfDsbC sample
was dialyzed overnight against buffer B (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl) at 4 °C. The determination of
the redox states of purified XfDsbC was achieved using
Ellman’s method [49]. The protein concentration was
spectrophotometrically determined and calculated from the
A280 with a molar absorption coefficient (e280) of
23 630 M1cm1, assuming that all Cys residues were oxi-
dized, or 23 380 M1cm1, assuming that all Cys residues
were reduced.
Biochemical assays and disulfide bond
isomerization in vivo
The in vitro thiol-disulfide reductase activity of XfDsbC
was determined by measuring the turbidity increase at
650 nm resulting from insulin reduction in accordance with
published procedures [50]. EcDsbC purified from the
JW2861 clone, as obtained from the ASKA library [51],
was used as a positive control in these tests. Reductase
activity was expressed as the ratio of the slope of the linear
portion of the turbidity curve to the lag time [52]. In addi-
tion, the XfDsbC disulfide bond isomerase activity was
assessed in vivo using a functional complementation assay
based on copper sensitivity [21]. The xfdsbC gene was
cloned into the pBAD24 vector [53] using the oligonucleo-
tides Xf1177badF (5′-ATCCATGGGTTACCGCCTTATC
GTCG-3′) and Xf1177badR (5′-AATGTCGACTCAGCC
CCCTTTAGCT-3′), which contained NcoI and SalI restric-
tion sites, respectively. pBAD24-xfdsbC or pBAD24 empty
vector was transformed into the E. coli JW2861 strain,
which is a dsbC deletion mutant derived from the wild-type
BW25113 strain. Both strains were kindly provided by the
National BioResource Project (NIG, Mishima, Japan). For
the copper sensitivity assay, the strains (wild-type, dsbC
and dsbC containing pBAD24-xfdsbC or the empty vec-
tor) were grown overnight in LB containing 30 lgmL1
chloramphenicol, 100 lgmL1 ampicillin or 30 lgmL1
kanamycin (depending on the strain) at 37 °C and 300 r.p.
m. The cultures were then diluted 1 : 100 in BHI media
supplemented with the appropriate antibiotic and grown at
37 °C and 300 r.p.m. until D600 of 0.8 was reached. The
dsbC phenotype was tested by spotting 5 lL of 10-fold
serial dilutions onto BHI agar plates with the appropriate
antibiotic containing 0, 4 and 8 mM CuCl2 with and with-
out 0.002% w/v L-arabinose. The plates were incubated
overnight at 37 °C, and the ability of XfDsbC to restore
the wild-type phenotype was analyzed. We reintroduced
wild-type EcDsbC, which was expressed from the pCA24N
plasmid [51], into the dsbC strain as a positive control for
functional complementation. All of the spot titrations were
performed in triplicate, and XfDsbC expression in the
dsbC strain was confirmed by western blot analysis.
Extraction of total protein from X. fastidiosa
biofilm and planktonic cells
X. fastidiosa biofilm and planktonic cells were collected after
3, 5, 10, 15, 20 and 30 days of growth. To assess the differen-
tial metal stress responses of the biofilm and planktonic cells,
both cell types were exposed to a sublethal copper shock for
24 h with 1 mM CuSO4. Biofilm and planktonic cells exposed
or not exposed to CuSO4 were sampled at various time
points, and total protein was extracted from each sample.
For total protein extraction, the biofilm and planktonic cells
from each treatment were collected and resuspended in 1 mL
of extraction buffer (50 mM Tris-HCl, pH 8.0, 25 mM NaCl,
5 mM EDTA and 2% Triton X-100) containing 1 mgmL1
lysozyme and 1 mM phenylmethanesulfonyl fluoride. The
samples were placed on ice for 20 min and lysed by sonica-
tion, followed by centrifugation (10 000 g for 10 min at 4 °
C). The total protein concentration of each protein sample
was normalized with a micro BCA protein assay kit (Thermo
Fisher Scientific Inc., Waltham, MA, USA) before SDS/
PAGE analysis. A BSA standard curve was utilized for the
total protein concentration comparison. The standard curve
exhibited an R2 of 0.989.
XfDsbC immunodetection during X. fastidiosa
biofilm and planktonic growth
Polyclonal antibodies against XfDsbC were produced by
Rheabiotech (Campinas, Brazil) and used in the XfDsbC
immunodetection assays. For western blot analysis, approx-
imately 105 lg of total X. fastidiosa protein from different
biofilm developmental phases and planktonic growth cul-
tures were separated using 12% SDS/PAGE. After electro-
phoresis, the proteins were transferred to nitrocellulose
membranes (ImmobilonTM-Nc; Sigma) using a Trans-Blot
Semi-Dry Transfer Cell (Bio-Rad, Hercules, CA, USA) in
accordance with the manufacturer’s instructions. XfDsbC
was detected with a 1 : 4000 dilution of anti-XfDsbC and
a 1 : 8000 dilution of alkaline phosphatase-conjugated
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anti-rabbit IgG (Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA). The membranes were developed with
NBT/BCIP chromogenic substrates (Promega, Madison,
WI, USA). Three independent experiments were performed
for each biological treatment to assess potential variations
in protein transfer. The signal intensity was quantified
using EDAS 290 software (Kodak, Rochester, NY, USA),
and the resulting values were subjected to statistical analy-
sis (P  0.05, t-test).
Native gel electrophoresis analysis
Nondenaturing PAGE was performed under the conditions
previously described for a pH range of 8.6–10.6 [54].
XfDsbC (pI = 9.01) protein samples (approximately 60 lg)
in the presence and absence of 3 mM TCEP reducing agent
were analyzed using 7.5% native gel electrophoresis with
aldolase (pI = 6.1, 158 kDa) and conalbumin (pI = 5.9,
75 kDa) (GE Healthcare, Uppsala, Sweden) as standards.
CD
The CD spectra of the recombinant XfDsbC were collected
on a Jasco J-810 Spectropolarimeter dichrograph (Japan
Spectroscopic, Tokyo, Japan). The far-UV CD spectra were
generated with XfDsbC at an approximate concentration
of 5 lM in 10 mM sodium phosphate buffer at pH 7.5 with
0 or 3 mM TCEP. The assays were performed in a quartz
cuvette with a path length of 1 mm, and 10 accumulations
within the range 260–190 nm at a rate of 50 nmmin1 at
24 °C were recorded for each sample and the mean was
determined. The deconvolution and statistical analysis of
the CD spectra were performed using DICHROWEB [55].
Size-exclusion chromatography
Gel filtration chromatography was performed using a pre-
packed Superdex 200 HR10⁄30 (GE Healthcare) column.
After equilibration of the column with buffer B, samples
(approximately 750 lg) containing 0 or 3 mM TCEP were
loaded at a flow rate of 0.5 mLmin1. The Superdex col-
umn was calibrated using HMW and LMW calibration kits
(GE Healthcare) as standard molecular weight markers.
DLS
DLS measurements were performed on a DynaPro instru-
ment (Protein Solutions Inc., Charlottesville, VA, USA).
XfDsbC samples at a concentration of 1 and 4 mgmL1 in
the absence or presence of 3 mM TCEP were analyzed in
buffer B. XfDsbCN-Red or XfDsbCRed samples (approxi-
mately 100 lL) were placed in a quartz cell and DLS mea-
surements were taken at 4 °C. At least 100 acquisitions of
5 s were collected for each condition tested.
Glutaraldehyde cross-linking
The oligomeric state of purified XfDsbC was determined
in vitro by chemical cross-linking with glutaraldehyde. The
protein samples (approximately 5 lM protein in 20 mM
Hepes buffer, pH 7.5, in a total volume of 100 lL) in the
presence or absence of 3 mM TCEP were incubated on ice
for 5 min with increasing concentrations (0–0.1%) of a
freshly prepared solution of glutaraldehyde. The reactions
were stopped by adding 10 lL of 1 M Tris-HCl, pH 8.0,
and the products were evaluated by SDS/PAGE and
western blot analysis using polyclonal antibodies against
XfDsbC.
Tryptophan fluorescence measurements
The tryptophan fluorescence spectra of XfDsbC were mea-
sured on an ISS K2 Fluorescence Spectrometer (ISS,
Champaign, IL, USA). Three independent experiments
were performed using 5 lM XfDsbC in the presence and
absence of 3 mM TCEP in buffer B. Excitation was per-
formed at a fixed wavelength of 280 nm, and emission
spectra were recorded in the range 300–400 nm. The fluo-
rescence contribution from the blank solutions containing
the reducing agent or not were subtracted from that of the
samples reduced or nonreduced, respectively.
SAXS data collection, processing and model
construction
XfDsbC samples were submitted for SAXS data collection.
XfDsbC at concentrations of 1, 4, 7 and 13 mgmL1 in
buffer B was incubated with 0 or 3 mM TCEP for 3 h
before the SAXS experiments. The samples were centri-
fuged at 13 000 g at 4 °C before use in the SAXS experi-
ments. The SAXS data collection was performed at the
SAXS-1 beamline at the Brazilian National Synchrotron
Light Laboratory (LNLS, Campinas, Brazil) [56] with a
Pilatus (300 K; 84 9 107 mm) 2D detector (Dectris Ltd,
Baden, Switzerland) and a monochromatic X-ray beam
with a wavelength of 1.3808 A˚. The sample-to-detector
distance was adjusted to 1101.50 mm to cover a momen-
tum transfer interval of 0.0158 < q < 0.4426 A˚1, where
q = [(4p)/(k)]sin h and 2h is the scattering angle. Individual
XfDsbC samples were carefully loaded into cells made of
two thin, parallel mica windows and maintained at 4 °C
during the measurements. The protein samples and buffer
solution were exposed to the X-ray beam in 1- to 5-min
frames. At least 10 successive frames were recorded for
each protein concentration and TCEP condition.
The data reduction was performed using FIT2D [57] with
radial integration of the collected images, and normaliza-
tion was performed relative to the intensity of the transmit-
ted beam after buffer scattering subtraction. The SAXS
data analyses were performed using ATSAS software [58].
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The Rg and scattering intensity at zero angle [I(0)] were
calculated using the indirect Fourier transform method
implemented in GNOM software [58], which also calculates
the distance distribution function P(r) and allows the
assessment of Dmax and molecule anisometry. Kratky plots
[q2I(q) 9 q] [59] were also generated to evaluate the confor-
mational variability of the protein in solution. The molecu-
lar weight of the protein was estimated using the SAXS
MoW algorithm [25].
Ab initio dummy bead models were calculated from the
experimental curves using DAMMIN and DAMMIF [56,60]. Dif-
ferent point-group symmetries (P1, P2 and P4) were
imposed, and the best results were obtained with P2 sym-
metry. The final low-resolution 3D envelope, which repre-
sents the protein, was generated by averaging independent
runs with DAMAVER and DAMFILT software [61] in automatic
mode. The individual and mean SAXS envelopes were
visually inspected.
In parallel with the ab initio methods used to construct
the low-resolution envelope from the experimental curve,
rigid-body modelling was performed. First, a monomeric
XfDsbC 3D homology model was obtained using the I-TAS-
SER server [62]. To assemble possible XfDsbC dimers and
tetramers, the I-TASSER XfDsbC models were superimposed
on the EcDsbC crystal structure (PDB code: 1EEJ) using
PYMOL (Schrodinger LLC, New York, NY, USA). Possible
XfDsbC dimerization interfaces were suggested based on
the EcDsbC dimeric structure [18]. The theoretical dimeric
XfDsbC atomic model was first modelled onto the SAXS
curve using BUNCH [63]. In this procedure, an XfDsbC
monomer was presented to the software with separate
dimerization and catalytic domains, and few restraints were
imposed in the reconstruction of the XfDsbC dimer.
The XfDsbC tetramer models were constructed using
SASREF software [64]. For this task, the catalytic and dimer-
ization domains were separately provided to the software,
and restrictions on the shortest and longest distances for
the independent domains were imposed. The dimerization
interface was restricted based on the results obtained with
the XfDsbC dimer model.
The discrepancy (v) between the experimental data and
the theoretical scattering curves computed for each possible
atomic model was assessed using CRYSOL software [64].
Conventionally, the v parameter, which is provided by
CRYSOL, is used as a measurement of the goodness of fit
to the experimental data. The structural alignments were
performed using SUPCOMB software [65].
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